CDER Ad Division Does Not Need Larger Staff, PhRMA Tells FDLI
Executive Summary
FDA's Division of Drug, Marketing & Communications should not increase the size of its advertising review staff, PhRMA General Counsel Russel Bantham told a Food & Drug Law Institute conference in Washington, D.C. April 18.